Respiratory

Study shows cigarette prices and age-of-sale laws impact youth smoking in the EU, with effects varying by region and gender.

Adjunctive low-dose glucocorticoids lower 30-day mortality in adults with community-acquired pneumonia in low-resource hospital settings.

A Swedish study found COVID-19 infection in pregnancy greatly raises preterm birth risk within 2 weeks, especially if unvaccinated. Vaccination offers key protection.

Tezepelumab reduced oral corticosteroid use in patients with severe asthma, with well-controlled asthma rising from 3% to 27% after 1 year.

Real-world study finds anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD patients, with major hospitalisation prevention.

Younger adults with early-onset lung cancer face poorer survival linked to late diagnosis, income, and access to care, highlighting urgent equity needs.

A Taiwanese study identifies lncZPBP2-3 as a pollution-responsive gene variant that heightens asthma risk with long-term PM2.5 exposure.

The MUSIC trial shows high-dose fluticasone elevates sputum bacterial load in severe COPD, without affecting upper airway microbiome, and ICS withdrawal can trigger exacerbations.